Skip to main content
Drug bottle and Pill

Compare Januvia vs. Tradjenta

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Januvia (sitagliptin) and Tradjenta (linagliptin) are both prescription medications used to treat Type 2 diabetes and belong to the same drug class, dipeptidyl peptidase 4 (DPP-4) inhibitors. Januvia is typically taken at 100 mg once daily, while Tradjenta is taken at 5 mg once daily. One key difference is that Januvia may require dose adjustments for people with kidney problems, whereas those can take Tradjenta for people with kidney or liver issues without dose changes. Common side effects for Januvia include a runny nose, sore throat, and headache, while Tradjenta may cause runny nose, sneezing, and diarrhea. Both medications can cause severe joint pain and have rare risks of pancreatitis and heart failure. However, Tradjenta has a higher reported rate of common cold symptoms compared to Januvia. Neither medication is known to affect body weight significantly on its own, but weight changes can occur when taken with other diabetes medications.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.